Quality of life improvements following one year of setmelanotide in children and adult patients with Bardet–Biedl syndrome: phase 3 trial results

[1]  K. Clément,et al.  Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period. , 2022, The lancet. Diabetes & endocrinology.

[2]  D. J. Driscoll,et al.  Critical review of bariatric surgical outcomes in patients with Prader‐Willi syndrome and other hyperphagic disorders , 2022, Obesity.

[3]  S. Fehnel,et al.  Understanding the Patient Experience of Hunger and Improved Quality of Life with Setmelanotide Treatment in POMC and LEPR Deficiencies , 2022, Advances in Therapy.

[4]  K. Clément,et al.  Quality of life outcomes in two phase 3 trials of setmelanotide in patients with obesity due to LEPR or POMC deficiency , 2022, Orphanet Journal of Rare Diseases.

[5]  Gitanjali Srivastava,et al.  Evaluation and Management of Early Onset Genetic Obesity in Childhood , 2021, Journal of Pediatric Genetics.

[6]  J. Yanovski,et al.  The efficacy and safety of setmelanotide in individuals with Bardet-Biedl syndrome or Alström syndrome: Phase 3 trial design , 2021, Contemporary clinical trials communications.

[7]  A. Haqq,et al.  The Complexity and Stigma of Pediatric Obesity , 2021, Childhood obesity.

[8]  T. Wadden,et al.  Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial , 2021, The Lancet.

[9]  J. Romijn,et al.  Bariatric Surgery for Monogenic Non-syndromic and Syndromic Obesity Disorders , 2020, Current Diabetes Reports.

[10]  R. Berg,et al.  Bardet‐Biedl syndrome: Weight patterns and genetics in a rare obesity syndrome , 2020, Pediatric obesity.

[11]  J. Yanovski,et al.  Effect of setmelanotide, a melanocortin‐4 receptor agonist, on obesity in Bardet‐Biedl syndrome , 2020, Diabetes, obesity & metabolism.

[12]  H. Buiting,et al.  Importance of Quality-of-Life Measurement Throughout the Disease Course. , 2020, JAMA network open.

[13]  F. Lordick,et al.  Association of Disease Progression With Health-Related Quality of Life Among Adults With Breast, Lung, Pancreatic, and Colorectal Cancer , 2020, JAMA network open.

[14]  F. Alkuraya,et al.  The morbid genome of ciliopathies: an update , 2020, Genetics in Medicine.

[15]  M. Alderfer,et al.  Pediatric Quality of Life Inventory (PedsQL) , 2020, Encyclopedia of Behavioral Medicine.

[16]  Y. Oh,et al.  Association between health related quality of life and progression of chronic kidney disease , 2019, Scientific Reports.

[17]  N. Hadker,et al.  PDB109 BURDEN OF ILLNESS ASSOCIATED WITH HYPERPHAGIA AND SEVERE OBESITY , 2019, Value in Health.

[18]  Arya M. Sharma,et al.  Addressing Internalized Weight Bias and Changing Damaged Social Identities for People Living With Obesity , 2019, Front. Psychol..

[19]  Tom R. Gaunt,et al.  Steroid receptor coactivator-1 modulates the function of Pomc neurons and energy homeostasis , 2019, Nature Communications.

[20]  W. Hul,et al.  Clinical, molecular genetics and therapeutic aspects of syndromic obesity , 2019, Clinical genetics.

[21]  P. Beales,et al.  Managing Bardet–Biedl Syndrome—Now and in the Future , 2018, Front. Pediatr..

[22]  C. L. le Roux,et al.  Morbidity and mortality associated with obesity. , 2017, Annals of translational medicine.

[23]  M Hassan Murad,et al.  Pediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline. , 2017, The Journal of clinical endocrinology and metabolism.

[24]  J. Lupski,et al.  Copy-Number Variation Contributes to the Mutational Load of Bardet-Biedl Syndrome. , 2016, American journal of human genetics.

[25]  K. Clément,et al.  Rare Genetic Forms of Obesity: Clinical Approach and Current Treatments in 2016 , 2016, Obesity Facts.

[26]  V. Sheffield,et al.  The BBSome Controls Energy Homeostasis by Mediating the Transport of the Leptin Receptor to the Plasma Membrane , 2016, PLoS genetics.

[27]  Julie C. Sapp,et al.  Characterization of Courtesy Stigma Perceived by Parents of Overweight Children with Bardet-Biedl Syndrome , 2015, PloS one.

[28]  D. Meyre,et al.  Obesity genetics in mouse and human: back and forth, and back again , 2015, PeerJ.

[29]  Gretchen A. Stevens,et al.  Global burden of cancer attributable to high body-mass index in 2012: a population-based study. , 2015, The Lancet. Oncology.

[30]  Julie C. Sapp,et al.  Hyperphagia among patients with Bardet‐Biedl syndrome , 2013, Pediatric obesity.

[31]  D. Valverde,et al.  Bardet-Biedl syndrome: A rare genetic disease , 2013, Journal of Pediatric Genetics.

[32]  P. Beales,et al.  Bardet–Biedl syndrome , 2012, European Journal of Human Genetics.

[33]  M. Leonardi,et al.  Obesity Is a Marker of Reduction in QoL and Disability , 2012, TheScientificWorldJournal.

[34]  V. Sheffield,et al.  Requirement of Bardet-Biedl syndrome proteins for leptin receptor signaling , 2009, Human molecular genetics.

[35]  Victor M. Montori,et al.  Prevention and Treatment of Pediatric Obesity: An Endocrine Society Clinical Practice Guideline Based on Expert Opinion , 2008, The Journal of clinical endocrinology and metabolism.

[36]  Tasha M Burwinkle,et al.  Impaired health-related quality of life in children and adolescents with chronic conditions: a comparative analysis of 10 disease clusters and 33 disease categories/severities utilizing the PedsQL™ 4.0 Generic Core Scales , 2007, Health and quality of life outcomes.

[37]  Haomiao Jia,et al.  The impact of obesity on health-related quality-of-life in the general adult US population. , 2005, Journal of public health.

[38]  G. R. Williams,et al.  An integrated method to determine meaningful changes in health-related quality of life. , 2004, Journal of clinical epidemiology.

[39]  Michael Seid,et al.  The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity. , 2003, Ambulatory pediatrics : the official journal of the Ambulatory Pediatric Association.

[40]  J. Varni,et al.  Health-related quality of life of severely obese children and adolescents. , 2003, JAMA.

[41]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[42]  Michael Seid,et al.  PedsQL™ 4.0: Reliability and Validity of the Pediatric Quality of Life Inventory™ Version 4.0 Generic Core Scales in Healthy and Patient Populations , 2001, Medical care.

[43]  D. Chapman,et al.  Self-reported body mass index and health-related quality of life: findings from the Behavioral Risk Factor Surveillance System. , 2001, Obesity research.

[44]  P. Beales,et al.  New criteria for improved diagnosis of Bardet-Biedl syndrome: results of a population survey , 1999, Journal of medical genetics.

[45]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[46]  M. Gunay‐Aygun,et al.  Bardet-Biedl Syndrome Overview , 1993 .